Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2000
11/09/2000WO2000066589A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/09/2000WO2000066581A1 Cyanopyrroles as progesterone receptor agonists
11/09/2000WO2000066574A1 2,1-benzisothiazoline 2,2-dioxides
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066570A1 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066560A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000DE19921424A1 Substituierte Benzoylketone Substituted benzoyl ketones
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000DE19920791A1 Substituierte Benzoylisoxazole Substituted benzoylisoxazoles
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371758A1 2,1-benzisothiazoline 2,2-dioxides
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2365776A1 Method for treating abnormal cell proliferation in the brain
11/08/2000EP1049744A1 Asymmetric cyanine dye quenchers
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049692A1 Novel bicyclene-substituted oxazolidinones
11/08/2000EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049682A1 Oxazolidinone combinatorial libraries, compositions and methods of preparation
11/08/2000EP0588917B1 Isoxazole and isothiazole compounds that enhance cognitive function
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/07/2000US6143909 Epoxidation; producing cryptophycin compounds having an epoxide functionality
11/07/2000US6143892 Process for making 5-substituted pyrazoles
11/07/2000US6143772 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof
11/07/2000US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143750 Alpha 1a adrenergic receptor antagonists
11/07/2000US6143741 Treating or preventing illnesses resulting from damaged endothelial cells such as atherosclerosis, thrombosis, restenosis, vessel spasm by administering hydroxylamine derivative
11/07/2000US6143696 Substituted 4-(3-alkenylbenzoyl)pyrazoles
11/07/2000CA2179306C Dopamine receptor ligands
11/07/2000CA2022747C Carboxylic acid derivatives
11/02/2000WO2000064884A1 Piperidyl-imidazole derivatives, their preparations and therapeutic uses
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064872A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
11/02/2000WO2000064445A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000037464A3 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
11/02/2000WO2000034273A3 3-(heterocyclyl)-substituted benzoylpyrazols
11/02/2000WO2000034272A3 3-(heterocyclyl)-benzoylpyrazole-derivatives
11/02/2000EP1048658A1 Alicyclic acylated heterocyclic derivatives
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1047693A1 Herbicides 3-(benzazol-4-yl)pyrimidine-dione-derivatives
11/02/2000EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
11/02/2000EP1047684A1 Substituted alpha,beta-anellated butyrolactones
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047423A1 Novel apoptosis inhibitors
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000EP0853619B1 Disubstituted piperidine derivatives
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000DE19921086A1 New stable 6-alkenyl- or 6-alkynyl-epothilone derivatives, are cell division regulators useful for treating malignant tumors, angiogenesis or chronic inflammatory disease
11/02/2000DE19919218A1 New peptide compounds, e.g. aza-heterocyclic substituted beta-alanine derivatives, are integrin receptor antagonists useful e.g. for treating atherosclerosis, cancer, osteoporosis, hypertension or inflammation
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2370607A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/01/2000CN1272109A Process for producing isooxazolidinedione compound
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
11/01/2000CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
10/2000
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140351 Ortho-anthranilamide derivatives as anti-coagulants
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
10/31/2000US6140338 For treating acute inflammatory diseases, chronic inflammatory diseases, acquired immune deficiency syndrome, cancer, ischemic reflow disorder and/or arteriosclerosis
10/31/2000US6140326 Morpholinones as light stabilizers
10/31/2000US6140322 For therapy or prophylaxis of hypoxia, such as in cases of cardiac arrest, stroke and neonatal hypoxia, neurodegenerative conditions including nerve degeneration and/or nerve necrosis in disorders such as ischaemia, epilepsy, hypoglycemia
10/31/2000US6140320 For treating hiv(human immunodeficiency virus) infections
10/31/2000US6140270 By reacting them with an amine compound and an acid or base; herbicides
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
10/26/2000WO2000063194A1 Sulfonamide derivatives having oxadiazole rings
10/26/2000WO2000063171A1 Tricyclic compounds
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2367395A1 Cyclic amine derivatives and use thereof
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
1 ... 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 ... 647